|
|
|
40
|
B012H
|
RETROVIR 10MG/ML SYR (GSK/COL) ZIDOVUDINE
|
ZIDOVUDINE
|
RETROVIR
|
240ML
|
BL
|
54.53
|
0.23
|
SYRUP
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B012H
|
RETROVIR 10MG/ML SYR (GSK) ZIDOVUDINE (BL)
|
ZIDOVUDINE
|
RETROVIR
|
240ML
|
BL
|
93.48
|
0.3895
|
ML
|
100
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
40
|
B012T
|
3TC 10MG/ML SOLUTION (GSK/COL) LAMIVUDINE
|
LAMIVUDINE
|
3TC
|
240ML
|
BL
|
59.88
|
0.25
|
SOLUTION
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B012T
|
3TC 10MG/ML SOLUTION (GSK) LAMIVUDI (BL)
|
LAMIVUDINE
|
3TC
|
240ML
|
BL
|
76.11
|
0.3171
|
ML
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NRTI
|
|
|
|
|
40
|
B0133
|
RETROVIR 10MG/ML INJ (GSK/COL) ZIDOVUDINE
|
ZIDOVUDINE
|
RETROVIR
|
5X20ML
|
C
|
181.77
|
36.35
|
INJECTION
|
0
|
VIAL
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B0133
|
RETROVIR 10MG/ML INJ (GSK) ZIDOVUDINE
|
ZIDOVUDINE
|
RETROVIR
|
5X20ML
|
BL
|
423.27
|
84.654
|
VIAL
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
NRTI
|
|
|
|
|
40
|
B021BA
|
EMPETUS 100MG TAB (EMC/COL) RITONAVIR
|
RITONAVIR
|
EMPETUS
|
30'S
|
BL
|
21.75
|
0.73
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08180808
|
HIV PROTEASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B021BA
|
EMPETUS 100MG TAB (EMC) RITONAVIR (BL)
|
RITONAVIR
|
EMPETUS
|
30'S
|
BL
|
24.46
|
0.8155
|
TAB
|
60
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08180808
|
HIV PROTEASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HIV PROTEASE INHIBITORS
|
|
|
|
|
40
|
B021BH
|
RITONAVIR 100MG TAB (MAT/AHI)
|
RITONAVIR
|
RITONAVIR
|
30'S
|
BL
|
35.88
|
1.20
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180808
|
HIV PROTEASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B021BL
|
APO-DARUNAVIR 600MG TAB (APO/COL)
|
DARUNAVIR
|
APO-DARUNAVIR
|
60'S
|
BL
|
951.41
|
15.86
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
08180808
|
HIV PROTEASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B021BM
|
ATAZANAVIR 300MG TAB (MAT/AHI)
|
ATAZANAVIR
|
ATAZANAVIR
|
30'S
|
BL
|
55.45
|
1.85
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180808
|
HIV PROTEASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B021BQ
|
APO-DARUNAVIR 600MG TAB (APO) DARUN (BL)
|
DARUNAVIR
|
APO-DARUNAVIR
|
60'S
|
BL
|
970.44
|
16.174
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08180808
|
HIV PROTEASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
30
|
HIV PROTEASE INHIBITORS
|
|
|
|
|
40
|
B031AN
|
EFAVIRENZ 600MG TAB (MCP/AHI)
|
EFAVIRENZ
|
EFAVIRENZ
|
30'S
|
BL
|
9.08
|
0.30
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180816
|
NNRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B031AN
|
EFAVIRENZ 600MG TAB (MCP) (BL)
|
EFAVIRENZ
|
EFAVIRENZ
|
30'S
|
BL
|
8.43
|
0.2809
|
TAB
|
60
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180816
|
NNRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NNRTI
|
|
|
|
|
40
|
B031AP
|
NEVIRAPINE 200MG TAB (MCP/AHI)
|
NEVIRAPINE
|
NEVIRAPINE
|
60'S
|
BL
|
9.41
|
0.16
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180816
|
NNRTI
|
2022-05-26
|
2024-03-31
|
Package Size Change
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-05-26
|
|
|
|
40
|
B031U
|
NEVIR 200MG TAB (EMC/COL) NEVIRAPINE
|
NEVIRAPINE
|
NEVIR
|
60'S
|
BL
|
10.19
|
0.17
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08180816
|
NNRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B031V
|
EFAVIRENZ 600MG TAB (MAT/AHI)
|
EFAVIRENZ
|
EFAVIRENZ
|
30'S
|
BL
|
14.68
|
0.49
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180816
|
NNRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B031Y
|
EFCURE 600MG TAB (EMC/COL) EFAVIRENZ
|
EFAVIRENZ
|
EFCURE
|
30'S
|
BL
|
11.42
|
0.38
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08180816
|
NNRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B031Y
|
EFCURE 600MG TAB (EMC) EFAVIRENZ (BL)
|
EFAVIRENZ
|
EFCURE
|
30'S
|
BL
|
25.01
|
0.8336
|
TAB
|
60
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08180816
|
NNRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NNRTI
|
|
|
|
|
40
|
B041AU
|
ALOCID 20MG CAP (CAR/COL) OMEPRAZOLE
|
OMEPRAZOLE
|
ALOCID
|
3X10
|
C
|
5.44
|
0.18
|
CAPSULE
|
0
|
CAP
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
562836
|
PROTON PUMP INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
GASTROINTESTINAL DRUGS
|
|